@article{e77bcf464e544d159156d33c81e4d001,
title = "Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism",
abstract = "Background & Aims: Mitochondrial dysfunction disrupts the synthesis and secretion of digestive enzymes in pancreatic acinar cells and plays a primary role in the etiology of exocrine pancreas disorders. However, the transcriptional mechanisms that regulate mitochondrial function to support acinar cell physiology are poorly understood. Here, we aim to elucidate the function of estrogen-related receptor γ (ERRγ) in pancreatic acinar cell mitochondrial homeostasis and energy production. Methods: Two models of ERRγ inhibition, GSK5182-treated wild-type mice and ERRγ conditional knock-out (cKO) mice, were established to investigate ERRγ function in the exocrine pancreas. To identify the functional role of ERRγ in pancreatic acinar cells, we performed histologic and transcriptome analysis with the pancreas isolated from ERRγ cKO mice. To determine the relevance of these findings for human disease, we analyzed transcriptome data from multiple independent human cohorts and conducted genetic association studies for ESRRG variants in 2 distinct human pancreatitis cohorts. Results: Blocking ERRγ function in mice by genetic deletion or inverse agonist treatment results in striking pancreatitis-like phenotypes accompanied by inflammation, fibrosis, and cell death. Mechanistically, loss of ERRγ in primary acini abrogates messenger RNA expression and protein levels of mitochondrial oxidative phosphorylation complex genes, resulting in defective acinar cell energetics. Mitochondrial dysfunction due to ERRγ deletion further triggers autophagy dysfunction, endoplasmic reticulum stress, and production of reactive oxygen species, ultimately leading to cell death. Interestingly, ERRγ-deficient acinar cells that escape cell death acquire ductal cell characteristics, indicating a role for ERRγ in acinar-to-ductal metaplasia. Consistent with our findings in ERRγ cKO mice, ERRγ expression was significantly reduced in patients with chronic pancreatitis compared with normal subjects. Furthermore, candidate locus region genetic association studies revealed multiple single nucleotide variants for ERRγ that are associated with chronic pancreatitis. Conclusions: Collectively, our findings highlight an essential role for ERRγ in maintaining the transcriptional program that supports acinar cell mitochondrial function and organellar homeostasis and provide a novel molecular link between ERRγ and exocrine pancreas disorders.",
author = "{North American Pancreatitis Study 2 (NAPS2) Consortium} and Jinhyuk Choi and Oh, {Tae Gyu} and Jung, {Hee Won} and Park, {Kun Young} and Hyemi Shin and Taehee Jo and Kang, {Du Seock} and Dipanjan Chanda and Sujung Hong and Jina Kim and Hayoung Hwang and Moongi Ji and Minkyo Jung and Takashi Shoji and Ayami Matsushima and Pilhan Kim and Mun, {Ji Young} and Paik, {Man Jeong} and Cho, {Sung Jin} and Lee, {In Kyu} and Whitcomb, {David C.} and Phil Greer and Brandon Blobner and Goodarzi, {Mark O.} and Pandol, {Stephen J.} and Rotter, {Jerome I.} and Weiwei Fan and Bapat, {Sagar P.} and Ye Zheng and Chris Liddle and Yu, {Ruth T.} and Atkins, {Annette R.} and Michael Downes and Eiji Yoshihara and Evans, {Ronald M.} and Suh, {Jae Myoung}",
note = "Funding Information: Funding This research was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T32 DK063922-17 (David C. Whitcomb, Brandon Blobner) and National Institutes of Health (NIH) DK061451 (David C. Whitcomb). This publication was also made possible in part by grant number UL1 RR024153 and UL1TR000005 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research (University of Pittsburgh. Principal investigator: Steven E. Reis, MD). Jerome I. Rotter was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the NIDDK Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute grant R01HL105756. Ji Young Mun and Minkyo Jung were supported by the KBRI Basic Research Program (ICT, 22-BR-01-03). Eiji Yoshihara was supported by Japan Society for the Promotion of Science, Kanae Medical Foundation, Allen Foundation, California Institute for Regenerative Medicine, and Juvenile Diabetes Research Foundation Ltd. Ronald Mark Evans was an investigator of the Howard Hughes Medical Institute and is the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute, and was supported by grants from the Lustgarten Foundation, the NOMIS Foundation–the Science of Health, a SWCRF Investigator Award, the David C. Copley Foundation, and the Don and Lorraine Freeberg Foundation. Research reported in this publication was supported by the NIDDK of the NIH under award number R01DK120480 (to Ronald Mark Evans). Jae Myoung Suh was supported by the Korea Advanced Institute of Science and Technology 2021 International Joint Research Support Program, National Research Foundation (2017M3A9G4052951, 2018R1A2A3075389, 2021M3A9G4016835, 2021R1A2C2007573) and Global Research Laboratory Program (2017K1A12013124) from the Ministry of Science and ICT of Korea. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR, NIDDK, or NIH. Funding Information: Funding This research was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T32 DK063922-17 (David C. Whitcomb, Brandon Blobner) and National Institutes of Health (NIH) DK061451 (David C. Whitcomb). This publication was also made possible in part by grant number UL1 RR024153 and UL1TR000005 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research ( University of Pittsburgh . Principal investigator : Steven E. Reis, MD). Jerome I. Rotter was supported in part by the National Center for Advancing Translational Sciences , CTSI grant UL1TR001881 , and the NIDDK Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center . Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute grant R01HL105756 . Eiji Yoshihara was supported by Japan Society for the Promotion of Science , Kanae Medical Foundation , Allen Foundation , California Institute for Regenerative Medicine , and Juvenile Diabetes Research Foundation Ltd . Ronald Mark Evans was an investigator of the Howard Hughes Medical Institute and is the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute, and was supported by grants from the Lustgarten Foundation , the NOMIS Foundation–the Science of Health , a SWCRF Investigator Award, the David C. Copley Foundation, and the Don and Lorraine Freeberg Foundation . Research reported in this publication was supported by the NIDDK of the NIH under award number R01DK120480 (to Ronald Mark Evans). Jae Myoung Suh was supported by the Korea Advanced Institute of Science and Technology 2021 International Joint Research Support Program, National Research Foundation ( 2017M3A9G4052951 , 2018R1A2A3075389 , 2021M3A9G4016835 , 2021R1A2C2007573 ) and Global Research Laboratory Program ( 2017K1A12013124 ) from the Ministry of Science and ICT of Korea. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR, NIDDK, or NIH. Publisher Copyright: {\textcopyright} 2022 AGA Institute",
year = "2022",
month = jul,
doi = "10.1053/j.gastro.2022.04.013",
language = "English",
volume = "163",
pages = "239--256",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",
}